David K. Butler
London, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Immune boosting by B.1.1.529 (Omicron) depends on previous SARS-CoV-2 exposure.
Journal: Science (New York, N.Y.)
Published: June 14, 2022
Heterologous infection and vaccination shapes immunity against SARS-CoV-2 variants.
Journal: Science (New York, N.Y.)
Published: December 02, 2021
HLA-DR polymorphism in SARS-CoV-2 infection and susceptibility to symptomatic COVID-19.
Journal: Immunology
Published: November 11, 2021
Antibody decay, T cell immunity and breakthrough infections following two SARS-CoV-2 vaccine doses in inflammatory bowel disease patients treated with infliximab and vedolizumab.
Journal: Nature communications
Published: September 30, 2021
BpOmpW Antigen Stimulates the Necessary Protective T-Cell Responses Against Melioidosis.
Journal: Frontiers in immunology
Published: August 30, 2021
Prior SARS-CoV-2 infection rescues B and T cell responses to variants after first vaccine dose.
Journal: Science (New York, N.Y.)
Published: February 21, 2021
Discordant neutralizing antibody and T cell responses in asymptomatic and mild SARS-CoV-2 infection.
Discordant neutralizing antibody and T cell responses in asymptomatic and mild SARS-CoV-2 infection.
Journal: Science immunology
Published: October 21, 2020
Post-acute COVID-19 associated with evidence of bystander T-cell activation and a recurring antibiotic-resistant bacterial pneumonia.
Journal: eLife
Published: September 24, 2020
Showing 1-8 of 8
Last Updated: 09/26/2026